Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Al-Naylam Pharmaceuticals CompanyNasdaq: ALLNEY) The best-performing large-cap company ($30+ billion) was in the pharmaceutical or biotechnology space in the second quarter, Yield ~58.5% In the period.The biotech company's strong…
